CFO
Joseph M. Busky is the Chief Financial Officer (CFO) of QuidelOrtho Corporation (QDEL), where he manages global financial operations, planning, and reporting, driving value creation for growth and long-term success.[[1]](https://theorg.com/org/quidelortho/org-chart/joseph-m-busky)[[3]](https://www.quidelortho.com/nl/en/our-company/leadership/joseph-busky) He joined Ortho Clinical Diagnostics (now part of QuidelOrtho) as CFO in July 2020 and assumed the role at QuidelOrtho in May 2022.[[1]](https://theorg.com/org/quidelortho/org-chart/joseph-m-busky)[[3]](https://www.quidelortho.com/nl/en/our-company/leadership/joseph-busky)[[4]](https://www.quidelortho.com/ca/en/resources/press-releases/ortho-clinical-diagnostics-names-joseph-m-busky-chief-financial-)[[7]](https://fintool.com/app/research/companies/QDEL/people/joseph-m-busky) On February 13, 2026, a trust associated with Busky purchased 3,370 shares of QDEL at $23.6623 per share, increasing his indirect holdings to 10,290 shares and direct holdings to 41,412 shares.[[2]](https://www.stocktitan.net/sec-filings/QDEL/form-4-quidel-ortho-corp-insider-trading-activity-6312db23a20e.html) He plans to retire effective June 30, 2026.[[5]](https://news.moomoo.com/flash/21886602/quidelortho-corp-cfo-joseph-m-busky-to-retire-effective-june)
Busky brings over 30 years of experience in corporate and operational finance across diagnostics, medical devices, telecom, and marketing services.[[1]](https://theorg.com/org/quidelortho/org-chart/joseph-m-busky)[[3]](https://www.quidelortho.com/nl/en/our-company/leadership/joseph-busky)[[4]](https://www.quidelortho.com/ca/en/resources/press-releases/ortho-clinical-diagnostics-names-joseph-m-busky-chief-financial-) His prior roles include CFO at Vyaire Medical, Inc., CFO at FDH Velocitel, seven years as CFO at InnerWorkings, Inc., and 11 years in finance roles at Siemens Medical Solutions Diagnostics/Dade Behring Holdings, Inc., Bayer Diagnostics, and Diagnostic Products Corporation, including Chief Accounting Officer at Dade Behring.[[1]](https://theorg.com/org/quidelortho/org-chart/joseph-m-busky)[[3]](https://www.quidelortho.com/nl/en/our-company/leadership/joseph-busky)[[4]](https://www.quidelortho.com/ca/en/resources/press-releases/ortho-clinical-diagnostics-names-joseph-m-busky-chief-financial-) He holds a BBA in Accounting, an MBA with a finance concentration from Loyola University in Baltimore, and is a CPA certified in Maryland.[[1]](https://theorg.com/org/quidelortho/org-chart/joseph-m-busky)[[3]](https://www.quidelortho.com/nl/en/our-company/leadership/joseph-busky)[[4]](https://www.quidelortho.com/ca/en/resources/press-releases/ortho-clinical-diagnostics-names-joseph-m-busky-chief-financial-) In 2023, his total compensation at QuidelOrtho was $2,943,018.[[6]](https://www.erieri.com/executive/salary/joseph-busky-20sw)
View full insider profile →
